Evidence mapPaperPMID 42512260Full record

ReviewCancers2026

Beyond Overdiagnosis: Evaluating the Drivers of Increasing Thyroid Cancer Incidence in the Era of Obesity, Environmental Exposure, and Advanced Diagnostics.

Marta Druszcz, Justyna Łapińska, Igor Kusio, Wiktoria Krowisz, Klaudia Gładowska, Weronika Pająk, Jakub Kleinrok, Ryszard Sitarz, Agnieszka Korolczuk

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marta DruszczDepartment of Clinical Pathomorphology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.ORCID 0009-0006-2398-1579
Justyna ŁapińskaDepartment of Clinical Pathomorphology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.ORCID 0009-0004-1569-8621
Igor KusioDepartment of Clinical Pathomorphology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.ORCID 0009-0007-8201-9870
Wiktoria KrowiszDepartment of Clinical Pathomorphology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.
Klaudia GładowskaStudent Scientific Society of Forensic Medicine, Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, 20-810 Lublin, Poland.ORCID 0009-0006-8130-527X
Weronika PająkDepartment of Clinical Pathomorphology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.ORCID 0009-0009-9616-0458
Jakub KleinrokDepartment of Clinical Pathomorphology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.ORCID 0009-0006-3742-5696
Ryszard Sitarz1st Department of Psychiatry, Psychotherapy and Early Intervention, Medical University of Lublin, Gluska Street 1, 20-439 Lublin, Poland.
Agnieszka KorolczukDepartment of Clinical Pathomorphology, Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland.ORCID 0000-0003-1016-2735

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global incidence of thyroid cancer (TC) has increased significantly in recent decades. Traditionally, this trend has been attributed to overdiagnosis resulting from the widespread use of imaging and improved diagnostic techniques, but increasing evidence suggests that current epidemiological patterns may not be fully explained by diagnostic factors alone. Most importantly, increasing rates of larger and more advanced tumors have been reported in several populations. This narrative review discusses the evidence on possible drivers of rising TC incidence: obesity and metabolic dysfunction, environmental exposures such as air pollution, and endocrine-disrupting chemicals (EDCs) and ionizing radiation, as well as molecular and genetic mechanisms involved in thyroid carcinogenesis. The role of advances in diagnostics and their contribution to overdiagnosis are also discussed. Current available data support a multifactorial model with better detection coupled with changes in environmental, metabolic and biological risk factors. A better understanding of the relative contribution and interaction of these determinants may help refine diagnostic strategies, reduce unnecessary interventions, and improve the prevention and management of TC.

Indexed as

endocrine-disrupting chemicalsenvironmental exposuresepidemiologyincidence trendsmolecular driversobesityoverdiagnosisthyroid cancer

Identifiers

PMID42512260
PMCPMC13406396

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.